New study on germline CDH1 variants shows lifetime cancer risks

Yüksel Ürün shared on X:

“New study on germline CDH1 variants shows lifetime cancer risks:

• Gastric cancer: 7% to 10% by age 80
• Breast cancer (female carriers): 37%
• These findings indicate a lower gastric cancer risk and similar breast cancer risk compared to previous estimates. Important for current management strategies in CDH1 variant carriers.”

Read further.
Source: Yüksel Ürün/X

Yüksel Ürün is a Medical Oncology professor at Ankara University School of Medicine in Turkey. His research focuses on genitourinary cancers, covering epidemiology, diagnosis, biomarkers, meta-analysis, and treatment outcomes. His dedication to patient care and research inspires positive change in the medical field.